Long Trade Idea
Enter your long position between $24.83 (the lower band of its horizontal support zone) and $25.39 (yesterday’s intra-day high).
Top Regulated Brokers
Market Index Analysis
- Pfizer (NYSE:PFE) is a member of the S&P 100 Index and the S&P 500 Index.
- Both indices remain near all-time highs, but bearish catalysts continue to accumulate, driven by rising inflationary pressures.
- The Bull Bear Power Indicator for the S&P 500 Index is bullish with a negative divergence.
Market Sentiment Analysis
Equity futures are drifting lower this morning following a two-day sell-off across the tech sector and ahead of tomorrow’s NVIDIA earnings, where expectations are sky-high to keep the AI bubble inflating. US President Trump apparently halted today’s planned attack on Iran after leaders from Qatar, Saudi Arabia, and the UAE asked him for a delay. Inflation worries and surging bond yields have cut through the AI mania and are now worrying some investors.
Pfizer Fundamental Analysis
Pfizer is a multinational pharmaceutical and biotechnology company. It specializes in immunology, oncology, cardiology, endocrinology, and neurology. PFE also ranks fifth among the most prominent biomedical companies by revenue.
So, why am I bullish on PFE despite its post-earnings slide?
Pfizer beat revenue and earnings per share expectations of $13.84 billion and $0.72, reporting $14.45 billion and $0.75, respectively, while also increasing its full-year 2026 guidance. I turned bullish amid its pipeline momentum, focused on oncology and metabolic diseases, including late-breaking data on elranatamab for multiple myeloma and sigvotatug vedotin for lung cancer. Strength in Padcev, Seagen, Nurtec, Prevnar, Vyndaqel, and BRAFTOVI reinforces my bullish case.
Metric | Value | Verdict |
P/E Ratio | 19.34 | Bullish |
P/B Ratio | 1.62 | Bullish |
PEG Ratio | 13.77 | Bearish |
Current Ratio | 1.25 | Bearish |
ROIC-WACC Ratio | Positive | Bullish |
Pfizer Fundamental Analysis Snapshot
The price-to-earnings (P/E) ratio of 19.34 makes PFE an inexpensive stock. By comparison, the P/E ratio for the S&P 500 Index is 31.88.
The average analyst price target for PFE is $29.19. This suggests moderate upside potential with fading downside risks.
Pfizer Technical Analysis
Today’s PFE Signal
Pfizer Price Chart
- The PFE D1 chart shows price action entering a massive horizontal support zone.
- It also shows price action between its descending 0.0% and 38.2% Fibonacci Retracement Fan levels.
- The Bull Bear Power Indicator is bearish but moved below its ascending trendline, hinting at more short-term volatility potential.
- The average bullish trading volumes are higher than the average bearish trading volumes since its last dividend payment.
- PFE moved lower as the S&P 500 Index advanced, a bearish signal, but bullish catalysts are rising.
My PFE Long Stock Trade
- PFE Entry Level: Between $24.83 and $25.39
- PFE Take Profit: Between $29.97 and $30.87
- PFE Stop Loss: Between $22.26 and $23.11
- Risk/Reward Ratio: 2.00
Ready to trade our analysis of PFE? Here is our list of the best stockbrokers worth checking out.